Company Overview of Diatide, Inc.
As of October 22, 1999, Diatide, Inc. was acquired by Schering Berlin, Inc. Diatide, Inc. is a development stage specialty pharmaceutical company engaged in the discovery, development, and commercialization of patented, disease-specific imaging agents, and therapeutics drugs for life-threatening diseases and conditions. The company is headquartered at Londonderry, New Hampshire.
Nine Delta Drive
Londonderry, NH 03053
Key Executives for Diatide, Inc.
Diatide, Inc. does not have any Key Executives recorded.
Similar Private Companies By Industry
|EpiBone, Inc.||United States|
|GlycoFi, Inc.||United States|
|Vandalia Research, Inc.||United States|
|Tinea Pharmaceuticals, Inc.||United States|
|Exiqon Diagnostics, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact Diatide, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.